Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06401603
What this trial is testing

A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Who this might be right for
Advanced Chronic Myeloid LeukemiaPhiladelphia Chromosome-Positive Acute Myeloid Leukemia
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00053001
What this trial is testing

Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome

Who this might be right for
AnemiaLeukemiaMyelodysplastic Syndromes+1 more
Fallon Clinic
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Early research (Phase 1)Study completedNCT00005064
What this trial is testing

PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome

Who this might be right for
Adult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaPreviously Treated Myelodysplastic Syndromes+5 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT00509249
What this trial is testing

Aflibercept in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndromes+3 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)UnknownNCT04835584
What this trial is testing

KRT-232 and TKI Study in Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Kartos Therapeutics, Inc. 109
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00109707
What this trial is testing

Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome+1 more
Novartis Pharmaceuticals 507
Testing effectiveness (Phase 2)Study completedNCT00274820
What this trial is testing

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Case Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT00593554
What this trial is testing

Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplasia+1 more
Sherif S. Farag 9
Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Testing effectiveness (Phase 2)Looking for participantsNCT03852407
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesChronic Myeloid Leukemia in Remission+7 more
University of Liege 114
Testing effectiveness (Phase 2)Looking for participantsNCT04838041
What this trial is testing

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia
Medical College of Wisconsin 51
Early research (Phase 1)Not Yet RecruitingNCT06530810
What this trial is testing

Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)

Who this might be right for
Chronic Myelogenous LeukemiaCML Chronic PhaseCML Accelerated Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Ended earlyNCT00451035
What this trial is testing

Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia in Chronic Phase
Novartis Pharmaceuticals 29
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT01570868
What this trial is testing

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT02689440
What this trial is testing

Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 155
Testing effectiveness (Phase 2)Study completedNCT00481052
What this trial is testing

Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 74
Next Page